Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 128394, 9 pages
http://dx.doi.org/10.1155/2015/128394
Research Article

The Synergistic Beneficial Effects of Ginkgo Flavonoid and Coriolus versicolor Polysaccharide for Memory Improvements in a Mouse Model of Dementia

1College of Chemical Engineering, Nanjing Forestry University, 159 Long Pan Road, Nanjing 210037, China
2Jiangsu Key Laboratory of Biomass Based Green Fuels and Chemicals, 159 Long Pan Road, Nanjing 210037, China
3Department of Pharmacology, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China
4Jiangsu Kanion Pharmaceutical Co., Ltd., 58 Haichang South Road, Lianyungang 222001, China

Received 24 July 2014; Revised 28 September 2014; Accepted 13 October 2014

Academic Editor: Paul Siu-Po Ip

Copyright © 2015 Xianying Fang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. R. Jack and D. M. Holtzman, “Biomarker modeling of alzheimer's disease,” Neuron, vol. 80, no. 6, pp. 1347–1358, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Reitz and R. Mayeux, “Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers,” Biochemical Pharmacology, vol. 88, no. 4, pp. 640–651, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Rasool, A. Malik, M. S. Qureshi et al., “Recent updates in the treatment of neurodegenerative disorders using natural compounds,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 979730, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Li, M. S. Tan, T. Jiang, and L. Tan, “Microglia in Alzheimer’s disease,” BioMed Research International, vol. 2014, Article ID 437483, 7 pages, 2014. View at Publisher · View at Google Scholar
  5. R. G. Nagele, J. Wegiel, V. Venkataraman, H. Imaki, and K.-C. Wang, “Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease,” Neurobiology of Aging, vol. 25, no. 5, pp. 663–674, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Li, R. Zhao, K. Gao et al., “Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease,” Current Alzheimer Research, vol. 8, no. 1, pp. 67–80, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. L. F. Eng and R. S. Ghirnikar, “GFAP and astrogliosis,” Brain Pathology, vol. 4, no. 3, pp. 229–237, 1994. View at Publisher · View at Google Scholar · View at Scopus
  8. J. J. Rodríguez, M. Olabarria, A. Chvatal, and A. Verkhratsky, “Astroglia in dementia and Alzheimer's disease,” Cell Death and Differentiation, vol. 16, no. 3, pp. 378–385, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Yang, S. Dong, Q. Jiang, T. Kuang, and W. Huang, “Changes in expression of manganese superoxide dismutase, copper and zinc superoxide dismutase and catalase in Brachionus calyciflorus during the aging process,” PLoS ONE, vol. 8, no. 2, Article ID e57186, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Lei, X. Hua, M. Xiao, J. Ding, Q. Han, and G. Hu, “Impairments of astrocytes are involved in the d-galactose-induced brain aging,” Biochemical and Biophysical Research Communications, vol. 369, no. 4, pp. 1082–1087, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Chakrabarty, P. Bhat, S. Kumari et al., “Cortico-hippocampal salvage in chronic aluminium induced neurodegeneration by Celastruspaniculatus seed oil: neurobehavioural, biochemical, histological study,” Journal of Pharmacology and Pharmacotherapeutics, vol. 3, no. 2, pp. 161–171, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. W. N. Yang, X. D. Hu, H. Han et al., “The effects of valsartan on cognitive deficits induced by aluminum trichloride and d-galactose in mice,” Neurological Research, vol. 36, no. 7, pp. 651–658, 2014. View at Google Scholar
  13. T. Silva, J. Reis, J. Teixeira, and F. Borges, “Alzheimer's disease, enzyme targets and drug discovery struggles: from natural products to drug prototypes,” Ageing Research Reviews, vol. 15, no. 1, pp. 116–145, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Liu, M. Kong, S. Yuan, J. Liu, and P. Wang, “History and experience: a survey of traditional Chinese medicine treatment for Alzheimer's disease,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 642128, 5 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. N. T. Lautenschlager, R. Ihl, and W. E. Müller, “Ginkgo biloba extract EGb 761 in the context of current developments in the diagnosis and treatment of age-related cognitive decline and Alzheimer's disease: a research perspective,” International Psychogeriatrics, vol. 24, supplement 1, pp. S46–S50, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Serrano-García, J. Pedraza-Chaverri, J. J. Mares-Sámano et al., “Antiapoptotic effects of EGb 761,” Evidence-based Complementary and Alternative Medicine, vol. 2013, Article ID 495703, 18 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Xie, J.-R. Wang, L.-F. Yau et al., “Quantitative analysis of the flavonoid glycosides and terpene trilactones in the extract of ginkgo biloba and evaluation of their inhibitory activity towards fibril formation of β-amyloid peptide,” Molecules, vol. 19, no. 4, pp. 4466–4478, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Gao, Y. Inagaki, X. Li, N. Kokudo, and W. Tang, “Research progress on natural products from traditional Chinese medicine in treatment of Alzheimer's disease,” Drug Discoveries & Therapeutics, vol. 7, no. 2, pp. 46–57, 2013. View at Google Scholar
  19. J. T. Zhu, R. C. Choi, G. K. Chu et al., “Flavonoids possess neuroprotective effects on cultured pheochromocytoma PC12 cells: a comparison of different flavonoids in activating estrogenic effect and in preventing β-amyloid-induced cell death,” Journal of Agricultural and Food Chemistry, vol. 55, no. 6, pp. 2438–2445, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Ude, M. Schubert-Zsilavecz, and M. Wurglics, “Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients,” Clinical Pharmacokinetics, vol. 52, no. 9, pp. 727–749, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Weinmann, S. Roll, C. Schwarzbach, C. Vauth, and S. N. Willich, “Effects of Ginkgo biloba in dementia: systematic review and meta-analysis,” BMC Geriatrics, vol. 10, article 14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. D. W.-S. Cheung, C.-M. Koon, E. Wat et al., “A herbal formula containing roots of Salvia miltiorrhiza (Danshen) and Pueraria lobata (Gegen) inhibits inflammatory mediators in LPS-stimulated RAW 264.7 macrophages through inhibition of nuclear factor κb (NFκB) pathway,” Journal of Ethnopharmacology, vol. 145, no. 3, pp. 776–783, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Cui and Y. Chisti, “Polysaccharopeptides of Coriolus versicolor: physiological activity, uses, and production,” Biotechnology Advances, vol. 21, no. 2, pp. 109–122, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. K. K. Chu, S. S. S. Ho, and A. H. Chow, “Coriolus versicolor: a medicinal mushroom with promising immunotherapeutic values,” Journal of Clinical Pharmacology, vol. 42, no. 9, pp. 976–984, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Chen, X. Jin, L. Zhang, and L. Yang, “A study on the antioxidant effect of Coriolus versicolor polysaccharide in rat brain tissues,” African Journal of Traditional, Complementary, and Alternative Medicines, vol. 10, no. 6, pp. 481–484, 2013. View at Google Scholar
  26. X.-Y. Fang, W. Chen, J.-T. Fan et al., “Plant cyclopeptide RA-V kills human breast cancer cells by inducing mitochondria-mediated apoptosis through blocking PDK1-AKT interaction,” Toxicology and Applied Pharmacology, vol. 267, no. 1, pp. 95–103, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. X. Zhang, X. Fang, Z. Gao et al., “Axitinib, a selective inhibitor of vascular endothelial growth factor receptor, exerts an anticancer effect in melanoma through promoting antitumor immunity,” Anti-Cancer Drugs, vol. 25, no. 2, pp. 204–211, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Bromley-Brits, Y. Deng, and W. Song, “Morris water maze test for learning and memory deficits in Alzheimer's disease model mice,” Journal of Visualized Experiments, no. 53, Article ID e2920, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. M. X. Ma, Y. M. Chen, J. He, T. Zeng, and J. H. Wang, “Effects of morphine and its withdrawal on Y-maze spatial recognition memory in mice,” Neuroscience, vol. 147, no. 4, pp. 1059–1065, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Sato, K.-I. Tanaka, Y. Ohnishi, T. Teramoto, M. Irifune, and T. Nishikawa, “Effects of steroid hormones on (Na+, K+)-ATPase activity inhibition-induced amnesia on the step-through passive avoidance task in gonadectomized mice,” Pharmacological Research, vol. 49, no. 2, pp. 151–159, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. C. J. Jensen, A. Massie, and J. De Keyser, “Immune players in the CNS: the astrocyte,” Journal of Neuroimmune Pharmacology, vol. 8, no. 4, pp. 824–839, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. B. S. Oken, “Practice parameter: management of dementia (an evidence-based review),” Neurology, vol. 57, no. 12, article 2323, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. J. L. Crimins, A. Pooler, M. Polydoro, J. I. Luebke, and T. L. Spires-Jones, “The intersection of amyloid beta and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease,” Ageing Research Reviews, vol. 12, no. 3, pp. 757–763, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. X. Sun, L. Jin, and P. Ling, “Review of drugs for Alzheimer's disease,” Drug Discoveries & Therapeutics, vol. 6, no. 6, pp. 285–290, 2012. View at Google Scholar
  35. B. Zhang, C. Gaiteri, L.-G. Bodea et al., “Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease,” Cell, vol. 153, no. 3, pp. 707–720, 2013. View at Publisher · View at Google Scholar · View at Scopus